Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renin-angiotensin System Inhibitors”

36 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 36 results

Post-approval studies (Phase 4)Looking for participantsNCT06952608
What this trial is testing

Effect of Ciprofol on Intraoperative Hypotension in Elderly Patients Receiving Renin-angiotensin System Inhibitors

Who this might be right for
Intraoperative HypotensionCiprofolRenin-angiotensin System Inhibitors
Second Affiliated Hospital, School of Medicine, Zhejiang University 140
Not applicableStudy completedNCT01691781
What this trial is testing

The Renin-Angiotensin-Aldosterone System and Parathyroid Hormone Control: The RAAS-PARC Study

Who this might be right for
Hyperparathyroidism
Brigham and Women's Hospital 41
Large-scale testing (Phase 3)Ended earlyNCT04493359
What this trial is testing

Switch of Renin-Angiotensin System Inhibitors in Patients With Covid-19

Who this might be right for
Covid19Angiotensin II Receptor Antagonist Adverse Reaction
University of Sao Paulo 18
Large-scale testing (Phase 3)Study completedNCT00853658
What this trial is testing

Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure

Who this might be right for
Chronic Heart Failure
Novartis Pharmaceuticals 7,064
Not applicableStudy completedNCT04351581
What this trial is testing

Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19

Who this might be right for
Covid-19
University Hospital, Gentofte, Copenhagen 78
Large-scale testing (Phase 3)Study completedNCT00853827
What this trial is testing

Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients

Who this might be right for
Coronary Artery Disease (CAD)Coronary Atherosclerosis
Novartis Pharmaceuticals 613
Large-scale testing (Phase 3)Study completedNCT04591210
What this trial is testing

The COVID-RASi Trial (COVID-19)

Who this might be right for
COVID-19Cardiovascular Diseases
Ottawa Heart Institute Research Corporation 372
Testing effectiveness (Phase 2)Study completedNCT00920764
What this trial is testing

Atrasentan on Reducing Albuminuria in Type 2 Diabetic Nephropathy Treated With Renin-Angiotensin System Inhibitors

Who this might be right for
Chronic Kidney DiseaseDiabetic Nephropathy
AbbVie (prior sponsor, Abbott) 92
Large-scale testing (Phase 3)Looking for participantsNCT06862115
What this trial is testing

The Effect of Discontinuation of Renin Angiotensin System Inhibitors on the Perioperative Myocardial Injury in Adult Patients Undergoing Colorectal Cancer Surgery

Who this might be right for
Myocardium; InjuryPerioperative/Postoperative ComplicationsAngiotensin-Converting-Enzyme Inhibitor
Kasr El Aini Hospital 156
Post-approval studies (Phase 4)Not Yet RecruitingNCT07547878
What this trial is testing

Rapid and Simultaneous Initiation of Four Guideline-Directed CKD Therapies (RAPID-CKD)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 64
Not applicableUnknownNCT04374110
What this trial is testing

Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19

Who this might be right for
COVIDHypertensionCardiovascular Diseases+1 more
National Institute of Cardiology, Warsaw, Poland 1,000
Post-approval studies (Phase 4)Study completedNCT00400582
What this trial is testing

A Pharmacogenomic Study of Candesartan in Heart Failure

Who this might be right for
Heart Failure
Montreal Heart Institute 300
Not applicableStudy completedNCT03374449
What this trial is testing

Impact of Renin-Angiotensin System Inhibitors Continuation on Outcome After Major Surgery

Who this might be right for
Renin Angiotensin SystemSurgery
Assistance Publique - Hôpitaux de Paris 2,222
Not applicableStudy completedNCT01091961
What this trial is testing

Study of Preoperative Management of Angiotensin Converting Enzyme Inhibitor (ACEi) and Angiotensin Receptor Blocker (ARB) Medications

Who this might be right for
Hypertension
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 200
Not applicableUnknownNCT04374695
What this trial is testing

Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19

Who this might be right for
COVID-19
Versailles Hospital 700
Testing effectiveness (Phase 2)Study completedNCT00421733
What this trial is testing

The Effect of Paricalcitol Capsules on Reducing Albuminuria in Patients With Type 2 Diabetic Nephropathy Being Treated With Renin-angiotensin System Inhibitors

Who this might be right for
Diabetic NephropathyChronic Kidney Disease
Abbott 281
Post-approval studies (Phase 4)UnknownNCT03201185
What this trial is testing

Renin-angiotensin System Blockade Benefits in Clinical Evolution and Ventricular Remodeling After Transcatheter Aortic Valve Implantation (RASTAVI)

Who this might be right for
Transcatheter Aortic Valve ReplacemenAngiotensin-Converting Enzyme Inhibitors
Hospital Clínico Universitario de Valladolid 194
Large-scale testing (Phase 3)Study completedNCT00894387
What this trial is testing

Six Months Efficacy and Safety of Aliskiren Therapy on Top of Standard Therapy, on Morbidity and Mortality in Patients With Acute Decompensated Heart Failure

Who this might be right for
Acute Decompensated Heart FailureCongestive Heart Failure
Novartis Pharmaceuticals 1,639
Post-approval studies (Phase 4)Temporarily pausedNCT04330300
What this trial is testing

Coronavirus (COVID-19) ACEi/ARB Investigation

Who this might be right for
HypertensionCOVID-19
National University of Ireland, Galway, Ireland 2,414
Not applicableNot Yet RecruitingNCT07605390
What this trial is testing

RAndomized EHR-based Prescribing to Improve Disease-modifying Therapies for Cardio-Kidney-Metabolic Care (RAPID-CKM)

Who this might be right for
Chronic Kidney DiseaseType 2 Diabetes
Baylor Research Institute 600
Load More Results